EBC - ON DEMAND
P2Y12 inhibitor utilization in Bifurcation and Chronic Total Occlusion percutaneous coronary intervention with multiple drug-eluding stent (P2BiTO) registry
European Bifurcation Club 2014 – EBC 2014 – Bordeaux, France
P2Y12 inhibitor utilization in Bifurcation and Chronic Total Occlusion percutaneous coronary intervention with multiple drug-eluding stent (P2BiTO) registry
Author: Marco Zimarino, Institute of Cardiology, “G. d’Annunzio” University of Chieti, Italy
AIM
- To obtain an up-to-date descriptive analysis (registry) of the real-world attitude in the management of patients in the worst-case scenario, regardless the clinical setting (ACS or stable CAD)
- To verify the translation of the postulated different reduction in thrombosis rate among various P2Y12 inhibitors (clopidogrel, prasugrel and ticagrelor) in a high-risk setting such as the presence of ≥2 overlapping DES in CTO and bifurcation lesions.